Literature DB >> 300747

Characteristics of the immature cells involved in T cell-mediated enhancement of syngeneic tumor growth.

M Small.   

Abstract

Enhancement of tumor growth was observed when non-sensitized thymocytes were injected together with tumor cells into syngeneic mice, although this tumor enhancement was less pronounced than that caused by tumor-sensitized T lymphocytes. The cells within the thymus which are responsible for this tumor enhancement were found to be rapidly dividing and to be absent from the thymus a day after cortisone administration. At a longer time interval the cortison-depleted thymus was repopulated by dividing cells which exhibited tumor-enhancing reactivity. The characteristics of these cells suggest that they are in the early stages of thymic processing. The enhancing thymocytes were sensitive to treatment with the thymic humoral factor which functions in T cell maturation, and their enhancing activity was cancelled by such treatment. These results are compatible with our hypothesis that exposure of immature T cells to a tumor stimulus may lead to tumor enhancement whereas interaction between mature T lymphocytes and tumor cells may be required for tumor inhibition.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 300747

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

Review 1.  Immunology of metastasis. Can the immune response cope with disseminated tumor?

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

2.  Immune complexes in Indian kala-azar.

Authors:  S Sehgal; B K Aikat; A G Pathania
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

3.  Effect of different components of the thymic stroma on the onset of AKR leukaemia.

Authors:  M Fournier; E F Potworowski
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

4.  Enhancement of growth of a radiation-induced lymphoma by T cells from normal mice.

Authors:  A Gabizon; N Trainin
Journal:  Br J Cancer       Date:  1980-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.